Department of Biochemistry, Khartoum University, Sudan.
PLoS Negl Trop Dis. 2010 Aug 3;4(8):e776. doi: 10.1371/journal.pntd.0000776.
The Leishmania OligoC-TesT and NASBA-Oligochromatography (OC) were recently developed for simplified and standardised molecular detection of Leishmania parasites in clinical specimens. We here present the phase II evaluation of both tests for diagnosis of visceral leishmaniasis (VL), cutaneous leishmaniasis (CL) and post kala-azar dermal leishmaniasis (PKDL) in Sudan.
The diagnostic accuracy of the tests was evaluated on 90 confirmed and 90 suspected VL cases, 7 confirmed and 8 suspected CL cases, 2 confirmed PKDL cases and 50 healthy endemic controls from Gedarif state and Khartoum state in Sudan.
The OligoC-TesT as well as the NASBA-OC showed a sensitivity of 96.8% (95% CI: 83.8%-99.4%) on lymph node aspirates and of 96.2% (95% CI: 89.4%-98.7%) on blood from the confirmed VL cases. The sensitivity on bone marrow was 96.9% (95% CI: 89.3%-99.1%) and 95.3% (95% CI: 87.1%-98.4%) for the OligoC-TesT and NASBA-OC, respectively. All confirmed CL and PKDL cases were positive with both tests. On the suspected VL cases, we observed a positive OligoC-TesT and NASBA-OC result in 37.1% (95% CI: 23.2%-53.7%) and 34.3% (95% CI: 20.8%-50.9%) on lymph, in 72.7% (95% CI: 55.8%-84.9%) and 63.6% (95% CI: 46.6%-77.8%) on bone marrow and in 76.9% (95% CI: 49.7%-91.8%) and 69.2% (95% CI: 42.4%-87.3%) on blood. Seven out of 8 CL suspected cases were positive with both tests. The specificity on the healthy endemic controls was 90% (95% CI: 78.6%-95.7%) for the OligoC-TesT and 100% (95% CI: 92.9%-100.0%) for the NASBA-OC test.
Both tests showed high sensitivity on lymph, blood and tissue scrapings for diagnosis of VL, CL and PKDL in Sudan, but the specificity for clinical VL was significantly higher with NASBA-OC.
Leishmania OligoC-TesT 和 NASBA-Oligochromatography(OC)最近被开发用于简化和标准化临床标本中利什曼原虫寄生虫的分子检测。我们在此介绍了这两种检测方法在苏丹诊断内脏利什曼病(VL)、皮肤利什曼病(CL)和黑热病后皮肤利什曼病(PKDL)的 II 期评估。
在苏丹加达里夫州和喀土穆州,对 90 例确诊和 90 例疑似 VL 病例、7 例确诊和 8 例疑似 CL 病例、2 例确诊 PKDL 病例和 50 例健康地方病对照者进行了测试的诊断准确性评估。
OligoC-TesT 和 NASBA-OC 在淋巴结抽吸物中的敏感性分别为 96.8%(95%CI:83.8%-99.4%)和 96.2%(95%CI:89.4%-98.7%),在确诊 VL 病例的血液中的敏感性分别为 96.9%(95%CI:89.3%-99.1%)和 95.3%(95%CI:87.1%-98.4%)。两种检测方法均对所有确诊的 CL 和 PKDL 病例呈阳性。在疑似 VL 病例中,我们观察到 OligoC-TesT 和 NASBA-OC 的阳性结果分别为 37.1%(95%CI:23.2%-53.7%)和 34.3%(95%CI:20.8%-50.9%)在淋巴结中,在骨髓中的分别为 72.7%(95%CI:55.8%-84.9%)和 63.6%(95%CI:46.6%-77.8%),在血液中的分别为 76.9%(95%CI:49.7%-91.8%)和 69.2%(95%CI:42.4%-87.3%)。8 例疑似 CL 病例中有 7 例两种检测方法均呈阳性。在健康地方病对照者中,OligoC-TesT 的特异性为 90%(95%CI:78.6%-95.7%),NASBA-OC 检测方法的特异性为 100%(95%CI:92.9%-100.0%)。
这两种检测方法在苏丹对 VL、CL 和 PKDL 的诊断均具有较高的敏感性,但 NASBA-OC 对临床 VL 的特异性显著更高。